News

This is the largest fundraising campaign in Kentucky's history. It will focus on funding more student scholarships and growing UK's endowment to continue support for providing a world-class education and essential research to address the state's most pressing challenges.

With funds from NIH, Barbara Nikolajczyk is tracking the trajectory of type 2 diabetes. She's following metabolically healthy people as they naturally progress to diabetes, looking for potential drug targets along the way.

Thanks to work being done at UK, pastures at an area horse farm are becoming healthier and so are their mares and foals.

A UK neurologist who stumbled across a family with a gene mutation that can cause Lou Gehrig's Disease is merging science, medicine and family in a quest for a cure.

More than 45 of UK's students and recent graduates had the world's most prestigious scholarship, fellowship and internship organizations take note this year. The newest class of highly regarded scholars include UK’s 14th Truman Scholar and first Pickering Fellow.

Don Helme is partnering with the Kentucky Attorney General’s office to gauge public opinion on a new drug deactivation pouch, part of a larger effort to develop solutions to the state’s opioid epidemic.

Joe Chappell in the College of Pharmacy is partnering with Space Tango to test whether sending plants to space increases their ability to produce healing properties.

Carbon fiber is the material of the future — a next-generation version of aluminum. The good news for Kentucky manufacturers is that one of the leading carbon fiber research and development facilities in the world is located in their backyard, at the UK Center for Applied Energy Research.

The Office of the Vice President for Research sent Kaylynne Glover and Alexa Johnson to Washington D.C. for “CASE: Catalyzing Advocacy in Science and Engineering.” See what they learned.

Following in his father’s footsteps, Esias Bedingar came to UK in 2014 from Chad, not knowing any English at all. Since then, he has founded a nonprofit to help eradicate malaria in his home country, conducts research in neurodegenerative diseases, and will graduate with a degree in public health before attending Harvard University this fall.